Table 7. Barriers to prescribing metformin for prediabetes patients.

FDA: Food and Drug Administration

How strongly do you agree or disagree that the following are barriers to prescribing metformin? [5]
	Strongly disagree	Disagree	Neutral	Agree	Strongly agree
Patients do not like taking medications	2.0%	3.0%	28.7%	38.6%	27.7%
Medication cost to patient	11.9%	26.7%	37.6%	18.8%	5.0%
Poor patient adherence	2.0%	5.0%	33.7%	39.6%	19.8%
Potential side effects	4.0%	11.9%	34.7%	40.6%	8.9%
Providers' lack of awareness of clinical guidelines for metformin use	4.0%	13.9%	36.6%	38.6%	6.9%
Lack of FDA approval for metformin use in prediabetes	13.9%	26.7%	41.6%	15.8%	2.0%